Evaluation of the anti-oedematous effects of some H1-receptor antagonists and methysergide in rats

Pharmacological Research

Volumn 35, Issue 1, 1997, Pages 65-71

  Blazsó, Gábor ^a   Gábor, Miklós ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Croton oil ear oedema; H1 antagonists; Methysergide; Zymosan paw oedema

Indexed keywords

ASTEMIZOLE; CETIRIZINE; CLEMASTINE; CROTON OIL; CYPROHEPTADINE; DIMETINDENE; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE; METHYSERGIDE; SEROTONIN ANTAGONIST; TERFENADINE; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EDEMA; EXTERNAL EAR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030940449     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0104     Document Type: Article

References (31)

1. 1. Rocha E, Silva M, Antonio A. Pharmacological actions of antihistaminics. In: Rocha E, Silva M, Ed. Hdb Exp Pharm XVIII/2: Histamine II and Antihistaminics. Berlin-Heidelberg, New York: Springer, 1978: pp. 381-425.
2. 1-receptor antagonist dimethindene maleate. Agents Actions, Special Conference Issue 1992; C444-7.
3. 3. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med (NY) 1962; 111: 544-7.
4. 4. Van Arman CG, Begany AJ, Miller LM, Pless HH. Some details of the inflammation caused by yeast and carrageenin. J Pharm Exp Ther 1965; 150: 328-34.
5. 5. Tubaro A, Dri P, Delbello G, Zilli C, Dell Loggia R. The Croton oil ear test revisited. Agents Actions 1985; 17: 347-9.
6. 6. Soliman KFA, Soliman MRJ, Owasoyo JO, Walker CA. Diurnal variation in the phlogogenic response of rats to inflammatory agents. J Pharm Pharmacol 1983; 35: 388-9.
7. 7. Tarayre JP, Delhon A, Alliaga M, Barbara.M, Bruniquel F, Caillol V, Puech L, Consul N, Tisné-Versailles J. Pharmacological studies on zymosan inflammation in rats and mice. 1: Zymosan-induced paw oedema in rats and mice. Pharmacol Res 1989; 21: 375-83.
8. 8. Tubaro A, Dri P, Melato M, Mulas G, Bianchi P, Del Negro P, Dell Loggia R. In the croton oil ear test the effects of non steroidal antiinflammatory drugs (NSAIDs) are dependent on the dose of the irritant. Agents Actions 1986; 19: 371-3.
9. 9. Gemmel DK, Cottney J, Lewis AJ. Comparative effects of drugs on four paw oedema models in the rat. Agents Actions 1979; 9: 107-16.
10. 10. Junien JL, Lakatos C, Brohon J, Guillaume M, Sterne J. Anti-inflammatory effect of LA 2851 and reference drugs on some models of inflammation. Investigation of the mechanism of action. Agents Actions 1982; 12: 459-65.
11. 11. Damas J, Remacle-Volon G. Mast cell amines and the edema induced by zymosan and carrageenans in rats. Eur J Pharmacol 1986; 121: 367-76.
12. 12. Gado K, Gigler G. Zymosan inflammation: a new method suitable for evaluating new antiinflammatory drugs. Agents Actions 1991; 32: 119-21.
13. 13. Hugli TE, Muller-Eberhard HJ. Anaphylatoxins: C3a and C5a. Adv Immunol 1978; 26: 1-53.
14. 2. Prostaglandins 1985; 30: 769-89.
15. 15. Damas J, Remacle-Volon G. Influence of a long-acting bradykinin antagonist, Hoe 140, on some acute inflammatory reactions in the rat. Eur J Pharmacol 1992; 211: 81-6.
16. 16. Tonelli G, Thibault L, Ringler J. A bio-assay for the concomitant assessment of the antiphlogistic and thymolytic activities of topically applied corticoids. Endocrinology 1965; 77:625-34.
17. 17. Swingle KF, Reiter MJ, Schwartzmiller DH. Comparison of croton oil and cantharidin induced inflammations of the mouse ear and their modification by topically applied drugs. Arch Int Pharmaco 1981; 254: 168-76.
18. 18. Glenn ME, Bowman BJ, Rohloff NA. Simple laboratory procedures for the evaluation of topically-active antiinflammatory drugs. Agents Actions 1978; 8: 497-503.
19. 19. Haas HTA. Uber die Beeinflussung des Histamin-Gehalts der Haut durch Reizstoffe. Naunyn-Schmiedeberg's Arch Exp Path Pharmakol 1941; 197: 161-86.
20. 20. Haas HTA, Kraushaar A, Cordua CA. Reizstoffe und ihre Wirkungsweise. Naunyn-Schmiedeberg's Arch Exp Path Pharmakol 1950; 209: 138-64.
21. 21. Gábor M, Engi E. Effects of naturally occuring and semisynthetic flavonoids on mouse ear oedema induced with croton oil (in hung.) Kiserl Orvostud 1987; 39: 433-42.
22. 22. Gábor M, Rázga Zs. Influence of nonsteroidal antiphlogistics on mouse ear inflammation induced with croton oil. Arch Int Pharmaco 1989; 299: 241-6.
23. 23. Richards DM, Brogden RN, Heel RC, Speight TM, Avery GS. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1984; 28: 38-61.
24. 24. Sorkin EM, Heel RC. Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1985; 29: 34-56.
25. 1-receptor antagonists. Ann Allergy 1987; 66: 5-19.
26. 26. Nicholson AN. New antihistamines free of sedative side-effects. Trends Pharmacol Sci 1987; 8: 247-8.
27. 27. Campoli-Richards DM, Buckley MM-T, Fitton A. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs 1990; 40: 762-81.
28. 28. Haria M, Fitton A, Peters DH. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 1994; 48: 617-37.
29. 29. Kreutner W, Chapman RW, Gulbenkian A, Siegel MI. Antiallergic activity of loratadine, a non sedating antihistamine. Allergy 1987; 42: 57-63.
30. 3H] mepyramine from peripheral vs central nervous system receptors by loratadine, a non sedating antihistamine. Eur J Pharmacol 1986; 127: 153-5.
31. 31. Snyder SH, Snowman AM. Receptor effects of cetirizine. Ann Allergy 1987; 59: 4-8.